Inogen, Inc. (INGN) has a consensus analyst rating of Buy, based on 11 analysts covering the stock. Of those, 6 recommend buying, 4 recommend holding, and 1 recommend selling.
The analyst consensus price target for INGN is $26.00, representing a +310.1% upside from the current price of $6.34. Price targets range from a low of $26.00 to a high of $26.00.